IASIC Speaker Series Presents Marijuana and the Pediatric Patient

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed, organized, and guided by doctors.

Session: Marijuana and the Pediatric Patient: Psychosocial Screening and Intervention in the Age of Legal Marijuana
Presented By: 
Shannon Murphy, MD
Date: Tuesday, February 8, 2022
Time: 1:00PM Eastern/10:00AM Pacific
Price: FREE

Psychosocial screening is an essential part of the adolescent medical visit. Recent changes in marijuana laws around the country have impacted adolescent views on marijuana and teens’ perception of harm regarding marijuana use has decreased. Currently, marijuana now surpasses tobacco use for many young people. The adolescent visit is an important opportunity to address common misperceptions regarding use. This talk will give the provider an update on today’s marijuana and includes a). a brief review of those health effects that make the adolescent population particularly vulnerable to marijuana use, b). a discussion on cultural norms and how they affect adolescent and young adult use, and c). the importance of self-efficacy in choosing healthy behaviors.

Register For This FREE Session

View Upcoming Speakers

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

IASIC Speaker Series Presents  Cannabis and Mental Health

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Placebo Effect a Major Driver of Pain Reduction in Cannabis Trials

A strong placebo response may be largely responsible for the significant pain reduction observed in clinical trials of cannabis-based therapies, results of a new meta-analysis suggest. Investigators found that while the effect size of cannabinoids on pain intensity was significant, the placebo effect was about the same. “The data from the present meta-analysis, including 1459

Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005–2019

Since 2005, diagnoses of cannabis use disorder have increased substantially among VHA patients, as they have in the general population and other patient populations. Possible explanations warranting investigation include decreasing perception of risk, changing laws, increasing cannabis potency, stressors related to growing socioeconomic inequality, and use of cannabis to self-treat pain. Clinicians and the public

Cannabis legalization and cannabis-involved pregnancy hospitalizations in Colorado

The primary objective of this study was to evaluate the association between presence of recreational cannabis dispensaries and prevalence of cannabis-involved pregnancy hospitalizations in Colorado. This was a retrospective cohort study of pregnancy-related hospitalizations co-coded with cannabis diagnosis codes in the Colorado Hospital Association from January 1, 2011, through December 31, 2018 (recreational cannabis began

Scroll to Top